

Product Center

Product categories 



FluraVet Plus

Retail price

0.0

元

Market price

0.0

元

Number of views:

1000

Product serial number

Category

Dewormer

Quantity

Stock:



Large animal products：along@easternalong.com Small pet products：ca@easternalong.com

Back to list Contact Us

产品描述

Parameters

Description

Each ml of solution contains 280 mg fluralaner and 14 mg moxidectin.

Each pipette delivers:

	Unit dose	Fluralaner(mg)	Moxidectin(mg)
For small cats 1.2-2.8 kg	0.4 ml	112.5	5.6
For medium cats ＞ 2.8-6.25 kg	0.89 ml	250	12.5
For large cats ＞6.25 -12.5 kg	1.79 ml	500	25

Pharmaceutical Form

Spot-on solution.

Clear colourless to yellow solution.

Indications

Pharmacotherapeutic group: Antiparasitic products, insecticides and repellents, endectocides, milbemycins.

For cats with, or at risk from, mixed parasitic infestations by ticks or fleas and ear mites, gastrointestinal nematodes or heartworm. The veterinary medicinal product is exclusively indicated when use against ticks or fleas and one or more of the other target parasites is indicated at the same time.

For the treatment of tick and flea infestations in cats providing immediate and persistent flea (Ctenocephalides felis) and tick (Ixodes ricinus) killing activity for 12 weeks. Fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.

The product can be used as part of a treatment strategy for flea allergy dermatitis (FAD). For the treatment of infestations with ear mites (Otodectes cynotis).

For the treatment of infections with intestinal roundworm (4th stage larvae, immature adults and adults of Toxocara cati) and hookworm (4th stage larvae, immature adults and adults of Ancylostoma tubaeforme).

When administered repeatedly at a 12-week interval, the product continuously prevents heartworm disease caused by Dirofilaria immitis.

Dosage and Administration

Dosage schedule for cats:

For spot-on use.

This product is available in three pipette sizes. The following table defines the size of pipette to be used according to the body weight of the cat (corresponding to a dose of 40-94 mg fluralaner/kg body weight and 2-4.7 mg moxidectin/kg body weight):

Body weight (kg)	Pipette size to be used	Volume (ml)
1.2-2.8	For small cats	0.4
＞ 2.8-6.25	For medium cats	0.89
＞6.25-12.5	For large cats	1.79

Within each weight band, the content of one whole pipette should be used. For cats more than 12.5 kg, use a combination of two pipettes that most closely matches the body weight.

Method of administration

For external use only.

Remove one pipette from the package. Then hold the pipette in an upright position, and twist and pull off the cap. Reverse the cap and use it to twist and remove the seal from the pipette.

Part the fur on the animal's neck at the base of the skull until the skin is visible. Place the tip of the pipette on the skin and squeeze the pipette firmly several times to empty its contents directly onto the skin.

Application at the base of the skull will minimise the opportunity for the animal to lick the product. Apply only to undamaged skin.

Treatment

For the concurrent treatment of infections with ear mites (Otodectes cynotis), a single dose of the product should be applied. Seek further veterinary examination (i.e. otoscopy) 28 days after treatment to determine whether there is re-infestation requiring additional treatment. The choice of the additional treatment (monosubstance or combination product) should be determined by the prescribing veterinarian.

For the concurrent treatment of infections with the gastrointestinal nematodes T. cati and A. tubaeforme, a single dose of the product should be applied. The need for and frequency of re-treatment should be in accordance with the advice of the prescribing veterinarian and take into account the local epidemiological situation. Where necessary, cats can be re-treated at 12-week intervals.

Cats in areas endemic for heartworm, or cats which have travelled to endemic areas, may be infected with adult heartworms. Therefore prior to application of the product for the concurrent prevention of infection with adult D. immitis, the advice provided in section 4.4 should be considered.

At the time of treatment, the product is effective against D. immitis larvae (L3 and L4), which have infected the cat in the previous 30 days. The product is effective against incoming D. immitis larvae (L3) for 60 days after treatment. Therefore, for continuous prevention of heartworm disease cats need to be retreated at 12-week intervals.

Target species

Cats

Storage

Kept sealed and store above 30 °C.

Shelf life

2 years

Manufactured and Packaged By Eastern Along Pharmaceutical Co., Ltd